NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Valo Health

Valo Health

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.valohealth.com/

Last Round

Strategic

Jan 8, 2025

Est. Valuation

$2.8B

Total Funding Raised

$1.02B

Company Overview

Valo Health is a biotechnology company that leverages human-centric data and artificial intelligence through its Opal Computational Platform to streamline and accelerate the drug discovery and development process.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

AI drug discoverycausal AIdrug discovery platformin silico drug discoverybiotech AIcomputational biologytherapeutic developmenttarget identificationAI-driven pharmadrug pipelineknowledge graphsprecision medicineR&D partnership

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Valo Health Comparables

Compare Valo Health with similar companies based on industry and business-model similarity.

Valo Health comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Insitro
91%
Insilico Medicine
87%
Terray Therapeutics
83%

Valo Health Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJan 8, 2025
Series COct 28, 2022
M&ANov 15, 2021
SPAC Merger / PIPEJun 9, 2021
Series BMar 9, 2021
Series B
Jan 11, 2021

Key People

Founding team and executive leadership

Brian Alexander

Chief Executive Officer

Executive Team

Guido Lanza

SVP and CTO

Executive Team

Brett Blackman

Chief Innovation Officer, Head Of Corporate Business Development, Chief Operating Officer

Executive Team

Valo Health Investors

Notable investors and investment history

Valo Health investors
InvestorRounds
Hercules CapitalDebt
Global Founders CapitalSeries C
Khosla VenturesSPAC Merger / PIPE, M&A, Series B
MissionBlue Capital PartnersSeries B
Longevity Vision FundSPAC Merger / PIPE, Series C, M&A
Public Sector Pension Investment BoardSPAC Merger / PIPE, Series A, M&A, Series B
CAZ InvestmentsSPAC Merger / PIPE, M&A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 3, 2026

    Karin Conde-Knape appointed as the new Chief Scientific Officer.

  • Dec 2, 2025

    Rita Kale appointed as Chief Financial Officer.

Valo Health Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Valo Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Valo Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range212
Year Founded2019
Last FundingJan 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.